Skip to main content

Advertisement

Log in

The role of lateral lymph node dissection in the management of lower rectal cancer

  • Review Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Introduction

Lateral lymph node involvement is a problem encountered in patients with low rectal cancers. This has been documented in both anatomical and pathological studies. Currently, the vast majority of centers have concentrated on the use of chemoradiation to obtain better local control and manage these nodes indirectly. In Japan, extended nodal dissection for the control of pelvic nodal disease has seen further advancement. This paper discusses the key issues involved in the management of pelvic lateral nodes in low rectal cancers.

Methods

A review of available literature and critical appraisal of the entity of lateral nodes in low rectal cancers, the treatment options, and oncological and functional results were performed.

Results

There are good data showing that the entity of pelvic lateral nodes in low rectal cancers should not be ignored. Recent data have emerged showing that radiotherapy is associated with significant long-term functional side effects. Refinement of the technique, lateral node dissection, has led to good local control as well as good functional outcomes.

Conclusion

In this context, there needs to be a reevaluation of the role of chemoradiation as the sole treatment for lateral nodal disease in centers outside of Japan. Individualization of the treatment of rectal cancer may require all centers to be able to offer both modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Heald RJ, Moran BJ (1998) Embryology and anatomy of the rectum. Semin Surg Oncol 15(2):66–71

    Article  PubMed  CAS  Google Scholar 

  2. Funahashi K, Koike J, Shimada M, Okamoto K, Goto T, Teramoto T (2006) A preliminary study of the draining lymph node basin in advanced lower rectal cancer using a radioactive tracer. Dis Colon Rectum 49(10 Suppl):S53–58

    Article  PubMed  Google Scholar 

  3. Min BS, Kim JS, Kim NK, Lim JS, Lee KY, Cho CH, Sohn SK (2009) Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. Ann Surg Oncol 16(12):3271–3278

    Article  PubMed  Google Scholar 

  4. Akasu T, Sugihara K, Moriya Y (2009) Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 16(10):2779–2786

    Article  PubMed  Google Scholar 

  5. Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, Chang HJ, Lim SB, Choi HS, Park JG (2008) Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 15(3):729–737

    Article  PubMed  Google Scholar 

  6. Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T (2005) Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 92(6):756–763

    Article  PubMed  CAS  Google Scholar 

  7. Takahashi T, Ueno M, Azekura K, Ohta H (2000) Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 43(10 Suppl):S59–68

    Article  PubMed  CAS  Google Scholar 

  8. Yano H, Saito Y, Takeshita E, Miyake O, Ishizuka N (2007) Prediction of lateral pelvic node involvement in low rectal cancer by conventional computed tomography. Br J Surg 94(8):1014–1019

    Article  PubMed  CAS  Google Scholar 

  9. Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49(11):1663–1672

    Article  PubMed  Google Scholar 

  10. Fujita S, Yamamoto S, Akasu T, Moriya Y (2009) Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer. Int J Colorectal Dis 24(9):1085–1090

    Article  PubMed  Google Scholar 

  11. Tan KY, Yamamoto S, Fujita S, Akasu T, Moriya Y (2010) Improving prediction of lateral node spread in low rectal cancers—multivariate analysis of clinicopathological factors in 1,046 cases. Langenbecks Arch Surg/Deutsche Gesellschaft fur Chirurgie 395(5):545–549

    Google Scholar 

  12. Yano H, Moran BJ (2008) The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West. Br J Surg 95(1):33–49

    Article  PubMed  CAS  Google Scholar 

  13. Matsuoka H, Nakamura A, Masaki T, Sugiyama M, Nitatori T, Ohkura Y, Sakamoto A, Atomi Y (2007) Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res 27(5B):3529–3533

    PubMed  Google Scholar 

  14. Kim NK, Kim MJ, Park JK, Park SI, Min JS (2000) Preoperative staging of rectal cancer with MRI: accuracy and clinical usefulness. Ann Surg Oncol 7(10):732–737

    Article  PubMed  CAS  Google Scholar 

  15. Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10(11):1053–1062

    Article  PubMed  Google Scholar 

  16. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH, Wolff BG (1992) Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 174(1):27–32

    PubMed  CAS  Google Scholar 

  17. Regos J, Nagy L, Nagy Z, Morvay K (1990) Local recurrences following colorectal operations. Acta Chir Hung 31(2):117–124

    PubMed  CAS  Google Scholar 

  18. Lowry AC, Simmang CL, Boulos P, Farmer KC, Finan PJ, Hyman N, Killingback M, Lubowski DZ, Moore R, Penfold C, Savoca P, Stitz R, Tjandra JJ (2001) Consensus statement of definitions for anorectal physiology and rectal cancer: report of the Tripartite Consensus Conference on Definitions for Anorectal Physiology and Rectal Cancer, Washington, D.C., May 1, 1999. Dis Colon Rectum 44(7):915–919

    Article  PubMed  CAS  Google Scholar 

  19. Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69(10):613–616

    Article  PubMed  CAS  Google Scholar 

  20. Ferenschild FT, Dawson I, de Wilt JH, de Graaf EJ, Groenendijk RP, Tetteroo GW (2009) Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center. Int J Color Dis 24(8):923–929

    Article  Google Scholar 

  21. Tentes AA, Korakianitis OS, Veliovic D, Sgouridou E, Karagiozoglou C, Moustakas K (2010) The impact of total mesorectal excision in middle and low rectal carcinomas. J Buon 15(1):56–60

    PubMed  CAS  Google Scholar 

  22. de Chaisemartin C, Penna C, Goere D, Benoist S, Beauchet A, Julie C, Nordlinger B (2009) Presentation and prognosis of local recurrence after total mesorectal excision. Colorectal Dis 11(1):60–66

    Article  PubMed  Google Scholar 

  23. Moriya Y, Hojo K, Sawada T, Koyama Y (1989) Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32(4):307–315

    Article  PubMed  CAS  Google Scholar 

  24. Moriya Y, Sugihara K, Akasu T, Fujita S (1997) Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21(7):728–732

    Article  PubMed  CAS  Google Scholar 

  25. Koch M, Kienle P, Antolovic D, Buchler MW, Weitz J (2005) Is the lateral lymph node compartment relevant? Recent results in cancer research. Fortschr Krebsforschung 165:40–45

    Google Scholar 

  26. Syk E, Glimelius B, Nilsson PJ (2010) Factors influencing local failure in rectal cancer: analysis of 2315 patients from a population-based series. Dis Colon Rectum 53(5):744–752

    Article  PubMed  CAS  Google Scholar 

  27. Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL (2010) Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 36(5):470–476

    Article  PubMed  CAS  Google Scholar 

  28. Swedish R, Cancer T (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336(14):980–987

    Article  Google Scholar 

  29. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646

    Article  PubMed  CAS  Google Scholar 

  30. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess C, Karstens J, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740

    Article  PubMed  CAS  Google Scholar 

  31. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23(34):8697–8705

    Article  PubMed  Google Scholar 

  32. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2007) Late adverse effects of radiation therapy for rectal cancer—a systematic overview. Acta Oncol (Stockholm, Sweden) 46(4):504–516

    Article  Google Scholar 

  33. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2008) Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 95(2):206–213

    Article  PubMed  CAS  Google Scholar 

  34. Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn H, Rutten HJ, Wiggers T, Kranenbarg EK, Leer JW, Stiggelbout AM (2005) Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23(9):1847–1858

    Article  PubMed  Google Scholar 

  35. Braendengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund A, Glimelius B (2010) Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized phase iii study. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2010.07.007

  36. Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36(6):564–572

    Article  PubMed  CAS  Google Scholar 

  37. Stephens RJ, Thompson LC, Quirke P, Steele R, Grieve R, Couture J, Griffiths GO, Sebag-Montefiore D (2010) Impact of short-course preoperative radiotherapy for rectal cancer on patients’ quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. J Clin Oncol 28(27):4233–4239. doi:10.1200/JCO.2009.26.5264

    Article  PubMed  Google Scholar 

  38. Bruheim K, Tveit KM, Skovlund E, Balteskard L, Carlsen E, Fossa SD, Guren MG (2010) Sexual function in females after radiotherapy for rectal cancer. Acta Oncol (Stockholm, Sweden) 49(6):826–832. doi:10.3109/0284186X.2010.486411

    Article  Google Scholar 

  39. Moriya Y (2006) Function preservation in rectal cancer surgery. Int J Clin Oncol/Jpn Soc Clin Oncol 11(5):339–343

    Article  Google Scholar 

  40. Kusters M, Beets GL, van de Velde CJ, Beets-Tan RG, Marijnen CA, Rutten HJ, Putter H, Moriya Y (2009) A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg 249(2):229–235

    Article  PubMed  Google Scholar 

  41. Mann B (2004) Lateral lymph node dissection in rectal cancer patients: is there any indication? Int J Color Dis 19(3):195–196

    Article  Google Scholar 

  42. Sato H, Maeda K, Maruta M (2011) Prognostic significance of lateral lymph node dissection in node positive low rectal carcinoma. Int J Color Dis 26(7):881–889

    Article  Google Scholar 

  43. Matsuoka H, Masaki T, Sugiyama M, Atomi Y (2005) Impact of lateral pelvic lymph node dissection on evacuatory and urinary functions following low anterior resection for advanced rectal carcinoma. Langenbeck’s Arch Surg/DeSutsche Gesellschaft fur Chirurgie 390(6):517–522

    Google Scholar 

  44. Hojo K, Vernava AM 3rd, Sugihara K, Katumata K (1991) Preservation of urine voiding and sexual function after rectal cancer surgery. Dis Colon Rectum 34(7):532–539

    Article  PubMed  CAS  Google Scholar 

  45. Moriya Y, Sugihara K, Akasu T, Fujita S (1995) Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer. Eur J Cancer 31A(7–8):1229–1232

    Article  PubMed  CAS  Google Scholar 

  46. Uyama I, Sugioka A, Matsui H, Fujita J, Komori Y, Hanai T, Hasumi A (2001) Laparoscopic lateral node dissection with autonomic nerve preservation for advanced lower rectal cancer. J Am Coll Surg 193(5):579–584

    Article  PubMed  CAS  Google Scholar 

  47. Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, Kim JH, Mori T (2007) Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg 246(5):754–762

    Article  PubMed  Google Scholar 

  48. Saito N, Sarashina H, Nunomura M, Koda K, Takiguchi N, Nakajima N (1998) Clinical evaluation of nerve-sparing surgery combined with preoperative radiotherapy in advanced rectal cancer patients. Am J Surg 175(4):277–282

    Article  PubMed  CAS  Google Scholar 

  49. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 133(8):894–899

    Article  PubMed  CAS  Google Scholar 

  50. Bechtel J, Tepper J (2003) Adjuvant radiation therapy of patients with rectal cancer. Clin Colorectal Cancer 2(4):213–222

    Article  PubMed  Google Scholar 

  51. Wu ZY, Wan J, Li JH, Zhao G, Yao Y, Du JL, Liu QF, Peng L, Wang ZD, Huang ZM, Lin HH (2007) Prognostic value of lateral lymph node metastasis for advanced low rectal cancer. World J Gastroenterol 13(45):6048–6052

    Article  PubMed  Google Scholar 

  52. Arii K, Takifuji K, Yokoyama S, Matsuda K, Higashiguchi T, Tominaga T, Oku Y, Tani M, Yamaue H (2006) Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients. Langenbeck’s Arch Surg/Deutsche Gesellschaft fur Chirurgie 391(5):449–454

    Google Scholar 

  53. Tada M, Endo M (1995) Ultrasonographic examination for lateral lymphatic spread and local recurrence of rectal cancer. Preoperative detection and evaluation. Dis Colon Rectum 38(10):1047–1052

    Article  PubMed  CAS  Google Scholar 

  54. Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Sugihara K (2009) Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Dis Colon Rectum 52(4):567–576. doi:10.1007/DCR.0b013e3181a1d994

    Article  PubMed  Google Scholar 

  55. Shiozawa M, Akaike M, Yamada R, Godai T, Yamamoto N, Saito H, Sugimasa Y, Takemiya S, Rino Y, Imada T (2007) Lateral lymph node dissection for lower rectal cancer. Hepato-Gastroenterology 54(76):1066–1070

    PubMed  Google Scholar 

  56. Fujita S, Yamamoto S, Akasu T, Moriya Y (2003) Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 90(12):1580–1585. doi:10.1002/bjs.4350

    Article  PubMed  CAS  Google Scholar 

  57. Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JH, van de Velde CJ, Leer JW (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55(5):1311–1320

    Article  PubMed  CAS  Google Scholar 

  58. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246(5):693–701. doi:10.1097/01.sla.0000257358.56863.ce

    Article  PubMed  Google Scholar 

  59. Lim YK, Law WL, Liu R, Poon JT, Fan JF, Lo OS (2010) Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers. World J Surg Oncol 8:23. doi:10.1186/1477-7819-8-23

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

We declare that there are no conflicts of interests related to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kok-Yang Tan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Z., Loh, K.Y., Tan, KY. et al. The role of lateral lymph node dissection in the management of lower rectal cancer. Langenbecks Arch Surg 397, 353–361 (2012). https://doi.org/10.1007/s00423-011-0864-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-011-0864-x

Keywords

Navigation